Abstract
Fluoxetine is the only antidepressant that has been evaluated for treatment of pediatric depression in more than one randomized controlled trial, and it often is the initial medication selected for treatment of major depression in children and adolescents. Current guidelines suggest a change of medication at 6 to 8 weeks when patients have an insufficient response. To …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
